Oklahoma Heart Institute
Oklahoma Heart Institute
Tulsa, Oklahoma, United States21 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve insufficiency, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2026-10-07 | NCT05172973 | |
| A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease | cardiovascular disorder, heart disorder, heart failure, hypertensive disorder, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not applicable | 2026-10-06 | NCT07214376 | |
| The ENCIRCLE Trial | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2026-10-06 | NCT04153292 | |
| Early Feasibility Study - Edwards APTURE Transcatheter Shunt System | cardiovascular disorder, heart disorder, heart failure | Recruiting | Not applicable | 2026-10-02 | NCT03523416 | |
| Nectero EAST System Clinical Study | Aneurysm, abdominal aortic aneurysm, aortic aneurysm, aortic disorder, cardiovascular disorder, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-28 | NCT06001918 | |
| Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Recruiting | Not applicable | 2026-09-25 | NCT06183684 | |
| Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, atrial flutter, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Active, not recruiting | Not applicable | 2026-09-24 | NCT06735534 | |
| ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2026-09-24 | NCT05172960 | |
| remedē System Therapy Study | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, central sleep apnea syndrome, nervous system disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Active, not recruiting | Not stated | 2026-09-02 | NCT03884660 | |
| Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, persistent atrial fibrillation | Active, not recruiting | Not applicable | 2026-08-28 | NCT06096337 | |
| DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) | Hypoxia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, cardiovascular disorder, hypertensive disorder, interstitial lung disease, lung disorder, pulmonary hypertension, respiratory system disorder, vascular disorder | Recruiting | Not stated | 2026-08-26 | NCT06388421 | |
| xDot Access Management System Early Feasibility Study | Vascular Closure Devices | Recruiting | Not applicable | 2026-08-17 | NCT07464353 | |
| Assessment of CCM in HF With Higher Ejection Fraction | cardiovascular disorder, diastolic heart failure, heart disorder, heart failure | Recruiting | Not applicable | 2026-08-06 | NCT05064709 | |
| Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Active, not recruiting | Not applicable | 2026-07-08 | NCT03706833 | |
| ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not applicable | 2026-06-04 | NCT05686317 | |
| Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-03-06 | NCT03947619 | |
| TRISCEND II Pivotal Trial | cardiovascular disorder, heart disorder, heart failure, heart valve disorder, tricuspid valve disorder, tricuspid valve insufficiency | Active, not recruiting | Not applicable | 2026-02-27 | NCT04482062 | |
| PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR | Aortic Valve, Calcification of, Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Recruiting | Not applicable | 2025-12-17 | NCT04889872 | |
| A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Active, not recruiting | Phase 4 | 2025-12-09 | NCT05203510 | |
| CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Active, not recruiting | Phase 3 | 2025-12-01 | NCT05681351 | |
| Destination Therapy Post Approval Study | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Not stated | 2025-08-22 | NCT03681210 |